Products
Online Inquiry
Eprotirome
Cat. No.:
OB0225WX-1572
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Eprotirome is a synthetic mimetic of thyroid hormones that functions as a selective agonist for the thyroid hormone receptor.
Synonym:
KB2115; 355129-15-6; KB-2115; 3-((3,5-Dibromo-4-(4-hydroxy-3-(1-methylethyl)phenoxy)phenyl)amino)-3-oxopropanoic acid; 3-((3,5-Dibromo-4-(4-hydroxy-3-isopropylphenoxy)phenyl)amino)-3-oxopropanoic acid; Eprotiromo; Eprotiromum; 2-((3,5-dibromo-4-(4-hydroxy-3-(propan-2-yl)phenoxy)phenyl)carbamoyl)acetic acid; 2-({3,5-dibromo-4-[4-hydroxy-3-(propan-2-yl)phenoxy]phenyl}carbamoyl)acetic acid; 3-({3,5-dibromo-4-[4-hydroxy-3-(propan-2-yl)phenoxy]phenyl}amino)-3-oxopropanoic acid; KB 2115; Eprotirome (KB2115); 3-[3,5-dibromo-4-(4-hydroxy-3-propan-2-ylphenoxy)anilino]-3-oxopropanoic acid
CAS No.:
355129-15-6
Compound CID:
10299876
Formula:
C18H17Br2NO5
Formula Weight:
487.14
Specification
Relative Density:
1.708 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Eprotirome is applied in metabolic studies as a liver-selective thyroid hormone receptor beta agonist to examine its effects on serum cholesterol levels and lipid metabolism.
Library Information
Target:
THR
Receptor:
THR
Pathways:
Endocrinology/Hormones
Plate Number:
AOCL-21
Plate Location:
b7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
90 mg/mL; 184.75 mM
Ethanol Max Solubility:
30 mg/mL





